Related Experiment Videos
Acute respiratory failure in severe hematologic disorders
Critical Care Medicine
|January 1, 1984
Summary
Intensive therapy for acute respiratory failure in hematologic disorders showed poor outcomes. Most patients required mechanical ventilation, and survival rates were very low, highlighting challenges in managing these critical conditions.
Area of Science:
- Critical Care Medicine
- Hematology
- Pulmonology
Background:
- Acute respiratory failure (ARF) poses a severe threat to patients with hematologic disorders (HDs).
- These patients often exhibit poor response to conventional intensive therapies.
Purpose of the Study:
- To evaluate the effectiveness of intensive therapy in patients with hematologic disorders experiencing ARF.
- To analyze diagnostic methods and outcomes in this high-risk patient group.
Main Methods:
- Retrospective analysis of 30 patients with leukemia, bone-marrow aplasia, or lymphoma admitted to an intensive respiratory unit.
- Inclusion of patients receiving mechanical ventilation or continuous positive airway pressure (CPAP).
- Assessment of diagnostic accuracy for serology and transbronchial biopsy.
Main Results:
- All 30 patients presented with hypoxemia and poor response to high-concentration oxygen.
- Mechanical ventilation was required for 26 patients; 4 received CPAP.
- Only 6 patients (20%) recovered from ARF, with just 2 discharged; 80% of patients died in the unit.
Conclusions:
- Intensive therapy for ARF in hematologic disorders has a dismal prognosis.
- Diagnostic methods like serology and transbronchial biopsy showed limited accuracy.
- High mortality rates underscore the need for improved management strategies for ARF in HDs.